Market Place
Sourcing Support
All News #Library
Biotech
Scinai Immunotherapeutics Unveils $2.61M Private Placement
24 Apr 2026 //
PR NEWSWIRE BIO
Scinai Restructures Into CDMO Platform, Cuts R&D Scope
06 Apr 2026 //
PR NEWSWIRE
Scinai Reports 2025 Results: CDMO Revenues Double; Recipharm Deal
01 Apr 2026 //
PR NEWSWIRE
Scinai Bio Expands CDMO Services And Immunology Pipeline
19 Mar 2026 //
PR NEWSWIRE
Scinai Wins Israel Support for Fill-Finish Tech
25 Feb 2026 //
PR NEWSWIRE
Scinai CEO Amir Reichman Co-Leads Biopharma Manufacturing
07 Jan 2026 //
PR NEWSWIRE
Scinai Expands Fill-And-Finish CDMO With Israel Innovation
06 Oct 2025 //
PR NEWSWIRE
Scinai Showcases Strong 2025 CDMO Revenue Growth in Six-Month
02 Sep 2025 //
PR NEWSWIRE
Scinai Announces Annual Financial Results for 2024
07 May 2025 //
PR NEWSWIRE
Scinai to Showcase I&I pipeline and cGMP Biologics at BIO-Europe
17 Mar 2025 //
PR NEWSWIRE
Scinai to Showcase Biologics CDMO and I&I Pipeline at BIO-Europe
31 Oct 2024 //
PR NEWSWIRE
Scinai To Host Expert Panel On Plaque Psoriasis Treatment
16 Sep 2024 //
PR NEWSWIRE
Scinai to showcase its cGMP biologics CDMO and innovative NanoAb pipeline
29 Feb 2024 //
PR NEWSWIRE
Scinai Immunotherapeutics to Attend BIO-Europe Munich 2023
30 Oct 2023 //
GLOBENEWSWIRE
Scinai to Showcase its end-to-end cGMP Biologics CDMO Services at CPHI
04 Oct 2023 //
GLOBENEWSWIRE
BiondVax`s Inhaled Anti-SARS-CoV-2 NanoAb Virtually Prevented Illness
23 Jan 2023 //
GLOBENEWSWIRE
BiondVax`s Innovative Inhaled COVID-19 Therapy Virtually SARS-COV-2 Virus
06 Jan 2023 //
GLOBENEWSWIRE
Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.